Abstract
Practical Diabetes InternationalVolume 11, Issue 3 p. 102-103 Review ArticleFree Access Sulphonylurea-induced hypoglycaemia in elderly people with diabetes IW Campbell FRCP(Ed), Corresponding Author IW Campbell FRCP(Ed) Consultant Physician n/a@dne.dne Victoria Hospital, KirkcaldyCorrespondence to: Dr IW Campbell, Diabetic Department, Victoria Hospital, Kirkcaldy, Fife KY2 5AHSearch for more papers by this authorJ Chalmers MRCP(UK), J Chalmers MRCP(UK) Research Fellow Victoria Hospital, KirkcaldySearch for more papers by this authorOM Herlihy MB BCh(IRL), OM Herlihy MB BCh(IRL) Medical Registrar Victoria Hospital, KirkcaldySearch for more papers by this author IW Campbell FRCP(Ed), Corresponding Author IW Campbell FRCP(Ed) Consultant Physician n/a@dne.dne Victoria Hospital, KirkcaldyCorrespondence to: Dr IW Campbell, Diabetic Department, Victoria Hospital, Kirkcaldy, Fife KY2 5AHSearch for more papers by this authorJ Chalmers MRCP(UK), J Chalmers MRCP(UK) Research Fellow Victoria Hospital, KirkcaldySearch for more papers by this authorOM Herlihy MB BCh(IRL), OM Herlihy MB BCh(IRL) Medical Registrar Victoria Hospital, KirkcaldySearch for more papers by this author First published: 01 May 1994 https://doi.org/10.1002/j.1528-252X.1994.tb00019.xCitations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Berger W. Incidence of severe side-effects during therapy with sulphonylureas and biguanides. Horm Metab Res 1985; 15(Suppl): 111– 5 2Campbell IW. Metformin and the sulphonylureas: the comparative risk. Horm Metab Res 1985; 15(Suppl): 105– 11 3Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989; 34: 1231– 15 4Jennings AM, Wilson RM, Ward JD. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 1989: 12: 203– 8 5Ferner RE. Oral hypoglycemic agents. Med Clin North Am 1988; 72: 1323– 55 6Campbell IW. Hypoglycaemia and Type 2 diabetes: sulphonylureas. In: BM Frier, BM Fisher (eds). Hypoglycaemia and Diabetes. London: Edward Arnold. 1993. 387– 92 7Seltzer HS. Severe drug-induced hypoglycemia: a review. Comprehensive Therapy 1979; 5: 21– 9 8Palatrick W, Meaterall RC, Tenebein M. Clinical spectrum of sulfonylurea-overdose and experience with diazoxide therapy. Arch Intern Med 1991; 151: 1859– 62 9Marri G, Cozzolino G, Palumbo R. Glucagon in sulphonylurea hypoglycaemia. Lancet 1968: 1: 303– 4 10Asplund K, Wiholm B-E, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983; 24: 412– 7 11Asplund K, Wiholm B-E, Lundman B. Severe hypoglycaemia during treatment with glipizide. Diabet Med 1991: 8: 726– 31 Citing Literature Volume11, Issue3May/June 1994Pages 102-103 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
